TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ACON

Aclarion, Inc. - Common Stock

NASDAQ
$1.39
▼ $0.46 (-24.9%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 16 Nov 2026
H $3.61L $1.35-55.2%
$3.61$3.16$2.71$2.25$1.8$1.35$1.39
RSI (14)
Intraday · 15-minNeutral-5RSI 31DowntrendMACD Bullishfor day-trading context — not advice

Technical signal

Sell-35
RSI (14)28
oversold 30overbought 70
Trend
Downtrend
MACD
Bearish
Bollinger
Below lower band
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
$1.35
Resistance
$2.06
  • Price is below its 50-day average (medium-term weakness).
  • RSI is 28 — oversold, a level some traders read as a potential entry zone.

Signal backtest · 2026-02-13 → 2026-11-16

Strategy return
-29.2%
Buy & hold
-46.1%
Trades
6
Win rate
0%

$100,000.00 invested would be worth $70,830.09 (-29.2%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Aclarion, Inc.· Health Information Services

source: yahoo

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Sector
Healthcare
Industry
Health Information Services
Employees
10
Headquarters
Broomfield, United States
www.aclarion.com ↗

Fundamentals

No fundamental data is currently available for this listing from our data providers.

Recent news

News sentiment:▲ Positive3↑ · 2↓ · 3–
  • DocGo Inc. (DCGO) Reports Q3 Loss, Lags Revenue Estimates▼ Negative
    Zacks · 09 Nov 2026
  • Sonida Senior Living (SNDA) Reports Q3 Loss, Lags Revenue Estimates▼ Negative
    Zacks · 05 Nov 2026
  • Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue Estimates▲ Positive
    Zacks · 04 Nov 2026
  • Bausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue Estimates
  • Price is below the lower Bollinger Band (stretched to the downside).
  • Educational technical indicators — not investment advice. TradeOrgs does not place trades.

    — Neutral
    Zacks · 28 Oct 2026
  • HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates— Neutral
    Zacks · 27 Oct 2026
  • Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs▲ Positive
    GlobeNewswire · 22 Oct 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.